| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 164.05B | 192.50B | 197.95B | 190.46B | 175.92B |
| Gross Profit | 19.01B | 30.89B | 38.30B | 42.33B | 37.64B |
| EBITDA | 19.49B | 24.10B | 30.32B | 34.34B | 33.22B |
| Net Income | 122.70M | 955.84M | 3.03B | 4.20B | 3.86B |
Balance Sheet | |||||
| Total Assets | 166.58B | 172.04B | 168.72B | 173.38B | 180.84B |
| Cash, Cash Equivalents and Short-Term Investments | 25.57B | 33.90B | 31.42B | 37.53B | 41.27B |
| Total Debt | 19.62B | 8.95B | 13.44B | 20.59B | 22.47B |
| Total Liabilities | 89.46B | 93.56B | 89.34B | 94.44B | 105.96B |
| Stockholders Equity | 57.97B | 57.31B | 57.01B | 54.50B | 52.58B |
Cash Flow | |||||
| Free Cash Flow | 906.13M | 19.16B | 15.43B | 12.43B | 4.46B |
| Operating Cash Flow | 10.04B | 29.15B | 24.25B | 18.65B | 12.90B |
| Investing Cash Flow | -11.79B | -10.99B | -9.37B | -7.86B | -7.77B |
| Financing Cash Flow | -8.44B | -15.63B | -21.28B | -14.68B | -12.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$204.15B | 10.00 | 18.03% | 1.95% | 39.48% | -27.45% | |
71 Outperform | HK$159.39B | 7.30 | 41.37% | ― | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$145.66B | 15.82 | 10.49% | 3.41% | 17.13% | -18.63% | |
45 Neutral | HK$58.76B | -7.62 | -8.08% | 1.35% | -10.32% | -1232.89% | |
44 Neutral | HK$9.70B | 68.21 | 0.21% | 4.98% | -14.76% | -87.76% |